4.690PLN-0.11%Mkt Cap: 20.27M $P/E: —1d ago
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mob…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap20.27M $
Enterprise Value17.71M $
Revenue (TTM)7.60K $
Gross Profit-2.02M $
Net Income (TTM)-2.64M $
Revenue/Share0.0005 USD
Last Price4.690 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLGNMTC00017
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.53
EV/Revenue2330.30
P/S2667.77
P/B10.06
EPS (TTM)-0.62
EPS (Forward)—
52W Range
3.24535% of range7.330
52W High7.330 PLN
52W Low3.245 PLN
Profitability
Gross Margin-37909.52%
Oper. Margin-13387.50%
EBITDA Margin0.00%
Profit Margin-49671.43%
ROE-113.21%
ROA-67.92%
Growth
Revenue Growth220.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.83M $
CapEx (TTM)23.30K $
FCF Margin-22987.50%
FCF Yield-8.62%
Net Debt-188.43K $
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity0.21
Current Ratio1.77
Quick Ratio1.52
Book Value/Sh0.4660 PLN
Cash/Share0.1730 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.06M
Float10.73M
Insiders7.07%
Institutions8.83%
Technical
SMA 505.138 (-8.7%)
SMA 2004.979 (-5.8%)
Beta0.30
S&P 52W Chg20.25%
Avg Vol (30d)29.11K
Avg Vol (10d)15.50K
Technical Indicators
RSI (14)43.3
MACD-0.0957
MACD Signal-0.1100
MACD Hist.+0.0142
BB Upper4.953 PLN
BB Middle4.738 PLN
BB Lower4.523 PLN
BB Width9.06%
ATR (14)0.2239 PLN
Vol Ratio (20d)0.57x